Join
Live feed
·
INSIDERFilingvia Quantisnow
vTv Therapeutics Inc. logo

Director Akkaraju Srinivas was granted 106,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VTVT· vTv Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VTVT (vTv Therapeutics Inc.) and more on Quantisnow.